Molecular Imaging Market Size, Share, & Trends Analysis Report By Modality (Molecular Ultrasound Imaging, Positron Emission Tomography), By Application (Cardiovascular, Neurology), By End Use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED: April 11, 2025

PAGES: 120 Pages

DELIVERY TIME: 2-10 business days

SELECT AN OPTION

The global molecular imaging market size is estimated to reach USD 11.4 billion by 2030, expanding at a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.3% in 2024
The Nuclear Magnetic Resonance (NMR) spectrometer segment is anticipated to be the fastest-growing segment, with a CAGR of 8.8% from 2025 to 2030.
Based on application, Oncology segment accounted for the largest market share in 2024 due to the rising global cancer burden and the growing demand for advanced diagnostic solutions.
Based on end use, Hospitals segment held the largest market share in 2024 due to the increasing adoption of advanced imaging technologies in clinical settings.
The diagnostic imaging centers segment is projected to be the fastest-growing segment over the forecast period, driven by the ability to offer high-quality, specialized imaging procedures with efficient turnaround times compared to larger hospitals.
North America dominated the market with a share of 41. 4% in 2024.

Product Code: GVR-4-68040-374-6

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional Scope
- 1.2.5. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Modality Outlook
- 2.2.2. Application Outlook
- 2.2.3. End Use Outlook
- 2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Molecular Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrant
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
  - 3.3.2.1. Political Landscape
  - 3.3.2.2. Technological Landscape
  - 3.3.2.3. Economic Landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

4.1. Modality Segment Dashboard
4.2. Molecular Imaging Market: Modality Movement Analysis
4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. Molecular Ultrasound Imaging
- 4.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.5. Positron Emission Tomography (PET)
- 4.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.6. Single Photon Emission Computed Tomography (SPECT)
- 4.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
- 4.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
4.8. Others
- 4.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

5.1. Application Segment Dashboard
5.2. Molecular Imaging Market: Application Movement Analysis
5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Cardiovascular
- 5.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.5. Neurology
- 5.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.6. Oncology
- 5.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.7. Respiratory
- 5.7.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
5.8. Gastrointestinal
- 5.8.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. Molecular Imaging Market: End Use Movement Analysis
6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
- 6.5.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
6.6. Research Institutes
- 6.6.1. Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Molecular Imaging Market by Region: Key Takeaways
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key Country Dynamics
  - 7.4.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.1.3. Competitive Scenario
  - 7.4.1.4. U.S. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.2.3. Competitive Scenario
  - 7.4.2.4. Canada Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.4.3.3. Competitive Scenario
  - 7.4.3.4. Mexico Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.5. Europe
- 7.5.1. U.K.
  - 7.5.1.1. Key Country Dynamics
  - 7.5.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.1.3. Competitive Scenario
  - 7.5.1.4. U.K. Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.2.3. Competitive Scenario
  - 7.5.2.4. Germany Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.3.3. Competitive Scenario
  - 7.5.3.4. France Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.4.3. Competitive Scenario
  - 7.5.4.4. Italy Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.5.3. Competitive Scenario
  - 7.5.5.4. Spain Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Denmark
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.6.3. Competitive Scenario
  - 7.5.6.4. Denmark Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.7.3. Competitive Scenario
  - 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework/ Reimbursement Structure
  - 7.5.8.3. Competitive Scenario
  - 7.5.8.4. Norway Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Japan
  - 7.6.1.1. Key Country Dynamics
  - 7.6.1.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.1.3. Competitive Scenario
  - 7.6.1.4. Japan Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.2.3. Competitive Scenario
  - 7.6.2.4. China Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.6.3. India
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.3.3. Competitive Scenario
  - 7.6.3.4. India Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.4.3. Competitive Scenario
  - 7.6.4.4. Australia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.5.3. Competitive Scenario
  - 7.6.5.4. South Korea Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework/ Reimbursement Structure
  - 7.6.6.3. Competitive Scenario
  - 7.6.6.4. Thailand Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.7.2.3. Competitive Scenario
  - 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.7.3.3. Competitive Scenario
  - 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 to 2030 (USD Million)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.2.3. Competitive Scenario
  - 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.3.3. Competitive Scenario
  - 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.4.3. Competitive Scenario
  - 7.8.4.4. UAE Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework/ Reimbursement Structure
  - 7.8.5.3. Competitive Scenario
  - 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/ Competition Categorization
8.3. Vendor Landscape
- 8.3.1. Key Company Heat Map Analysis, 2024
8.4. Company Profiles
- 8.4.1. Bruker
  - 8.4.1.1. Company Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. GE HealthCare
  - 8.4.2.1. Company Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Siemens Healthineers AG
  - 8.4.3.1. Company Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Koninklijke Philips N.V.
  - 8.4.4.1. Company Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Canon Medical Systems Corporation
  - 8.4.5.1. Company Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Mediso Ltd.
  - 8.4.6.1. Company Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Cubresa Inc.
  - 8.4.7.1. Company Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Shimadzu Corporation
  - 8.4.8.1. Company Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. United Imaging Healthcare Co., Ltd.
  - 8.4.9.1. Company Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Positron
  - 8.4.10.1. Company Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

Product Code: GVR-4-68040-374-6

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Molecular Imaging Market, by Region, 2018 - 2030 (USD Million)
Table 4 Global Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 5 Global Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 6 Global Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 7 North America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 9 North America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 10 North America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 12 U.S. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 15 Canada Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 16 Canada Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 17 Mexico Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 18 Mexico Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 19 Mexico Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 20 Europe Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
Table 21 Europe Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 22 Europe Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 23 Europe Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 24 U.K. Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 25 U.K. Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 26 U.K. Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 27 Germany Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 28 Germany Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 29 Germany Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 30 France Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 31 France Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 32 France Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 33 Italy Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 34 Italy Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 35 Italy Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 36 Spain Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 37 Spain Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 38 Spain Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 39 Denmark Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 40 Denmark Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 41 Denmark Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 42 Sweden Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 43 Sweden Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 44 Sweden Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Norway Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 46 Norway Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 47 Norway Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 51 Asia Pacific Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 53 Japan Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 54 Japan Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 55 China Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 56 China Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 57 China Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 58 India Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 59 India Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 60 India Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Australia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 62 Australia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 63 Australia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 64 South Korea Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 65 South Korea Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 66 South Korea Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 68 Thailand Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 69 Thailand Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 72 Latin America Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 73 Latin America Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 74 Brazil Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 75 Brazil Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 76 Brazil Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 77 Argentina Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 78 Argentina Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 79 Argentina Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Molecular Imaging Market, by Country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 84 South Africa Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 85 South Africa Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 86 South Africa Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 90 UAE Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 91 UAE Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 92 UAE Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)
Table 93 Kuwait Molecular Imaging Market, by Modality, 2018 - 2030 (USD Million)
Table 94 Kuwait Molecular Imaging Market, by Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Molecular Imaging Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Molecular Imaging Market: Market Outlook
Fig. 10 Molecular Imaging Competitive Insights
Fig. 11 Parent Market Outlook
Fig. 12 Related/Ancillary Market Outlook
Fig. 13 Penetration and Growth Prospect Mapping
Fig. 14 Industry Value Chain Analysis
Fig. 15 Molecular Imaging Market Driver Impact
Fig. 16 Molecular Imaging Market Restraint Impact
Fig. 17 Molecular Imaging Market Strategic Initiatives Analysis
Fig. 18 Molecular Imaging Market: Modality Movement Analysis
Fig. 19 Molecular Imaging Market: Modality Outlook and Key Takeaways
Fig. 20 Molecular Ultrasound Imaging Market Estimates and Forecast, 2018 - 2030
Fig. 21 Positron Emission Tomography (PET) Market Estimates and Forecast, 2018 - 2030
Fig. 22 Single Photon Emission Computed Tomography (SPECT) Market Estimates and Forecast, 2018 - 2030
Fig. 23 Nuclear Magnetic Resonance (NMR) Spectrometer Market Estimates and Forecast, 2018 - 2030
Fig. 24 Others Market Estimates and Forecast, 2018 - 2030
Fig. 25 Molecular Imaging Market: Application Movement Analysis
Fig. 26 Molecular Imaging Market: Application Outlook and Key Takeaways
Fig. 27 Cardiovascular Market, 2018 - 2030 (USD Million)
Fig. 28 Neurology Market, 2018 - 2030 (USD Million)
Fig. 29 Oncology Market, 2018 - 2030 (USD Million)
Fig. 30 Respiratory Market, 2018 - 2030 (USD Million)
Fig. 31 Gastrointestinal Market, 2018 - 2030 (USD Million)
Fig. 32 Molecular Imaging Market: End Use Movement Analysis
Fig. 33 Molecular Imaging Market: End Use Outlook and Key Takeaways
Fig. 34 Hospitals Market, 2018 - 2030 (USD Million)
Fig. 35 Diagnostic Imaging Centers Market, 2018 - 2030 (USD Million)
Fig. 36 Research Institutes Market, 2018 - 2030 (USD Million)
Fig. 37 Global Molecular Imaging Market: Regional Movement Analysis
Fig. 31 Global Molecular Imaging Market: Regional Outlook and Key Takeaways
Fig. 38 North America Market Estimates and Forecasts, 2018 - 2030
Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
Fig. 40 Canada Market Estimates and Forecasts, 2018 - 2030
Fig. 41 Mexico Market Estimates and Forecasts, 2018 - 2030
Fig. 42 Europe Market Estimates and Forecasts, 2018 - 2030
Fig. 43 U.K. Market Estimates and Forecasts, 2018 - 2030
Fig. 44 Germany Market Estimates and Forecasts, 2018 - 2030
Fig. 45 France Market Estimates and Forecasts, 2018 - 2030
Fig. 46 Italy Market Estimates and Forecasts, 2018 - 2030
Fig. 47 Spain Market Estimates and Forecasts, 2018 - 2030
Fig. 48 Denmark Market Estimates and Forecasts, 2018 - 2030
Fig. 49 Sweden Market Estimates and Forecasts, 2018 - 2030
Fig. 50 Norway Market Estimates and Forecasts, 2018 - 2030
Fig. 51 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
Fig. 52 Japan Market Estimates and Forecasts, 2018 - 2030
Fig. 53 China Market Estimates and Forecasts, 2018 - 2030
Fig. 54 India Market Estimates and Forecasts, 2018 - 2030
Fig. 55 Australia Market Estimates and Forecasts, 2018 - 2030
Fig. 56 South Korea Market Estimates and Forecasts, 2018 - 2030
Fig. 57 Thailand Market Estimates and Forecasts, 2018 - 2030
Fig. 58 Latin America Market Estimates and Forecasts, 2018 - 2030
Fig. 59 Brazil Market Estimates and Forecasts, 2018 - 2030
Fig. 60 Argentina Market Estimates and Forecasts, 2018 - 2030
Fig. 61 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 62 South Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 63 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
Fig. 64 UAE Market Estimates and Forecasts, 2018 - 2030
Fig. 65 Kuwait Market Estimates and Forecasts, 2018 - 2030